menu
    • menu

    Company profile for JenaValve

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    JenaValve’s device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. At a very early state, it became clear to our research and development as well as clinical teams ...
    JenaValve’s device idea was conceived by Hans-Reiner Figulla, MD, and Markus Ferrari, MD, both cardiologists at the Friedrich Schiller University Clinic, Jena, Germany. In 2006 the company was founded to develop second generation transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. At a very early state, it became clear to our research and development as well as clinical teams that safety, precision and durability are key for successful treatment, and ultimately, patient well-being.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    JenaValveUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7545 Irvine Center Drive Suite 100 Irvine, California 92618
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jenavalve.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JenaValve Launches Trilogy in US for Severe Aortic Regurgitation
    JenaValve Launches Trilogy in US for Severe Aortic Regurgitation

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266558/0/en/JenaValve-Announces-the-Start-of-Commercialization-of-the-Trilogy-Transcatheter-Heart-Valve-System-in-the-United-States-the-First-and-Only-Transcatheter-Device-Approved-for-Symptom.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Jenavalve Secures FDA's 1st Approval In Aortic Regurgitation
    Jenavalve Secures FDA's 1st Approval In Aortic Regurgitation

    18 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/jenavalves-trilogy-valve-secures-fdas-first-approval-aortic-regurgitation

    FIERCE BIOTECH
    18 Mar 2026
    Share Share
    Jenavalve Appoints John Molyneux To Vice President Of Operations
    Jenavalve Appoints John Molyneux To Vice President Of Operations

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228672/0/en/JenaValve-Appoints-John-Molyneux-to-Vice-President-of-Operations.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    FTC wins blocking Edwards Lifesciences' acquisition of JenaValve
    FTC wins blocking Edwards Lifesciences' acquisition of JenaValve

    09 Jan 2026

    // REUTERS

    https://www.reuters.com/world/ftc-wins-ruling-blocking-edwards-lifesciences-acquisition-jenavalve-2026-01-09/

    REUTERS
    09 Jan 2026
    Share Share
    Edwards Comments On Jenavalve Acquisition
    Edwards Comments On Jenavalve Acquisition

    09 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260109944511/en/Edwards-Comments-on-JenaValve-Acquisition

    BUSINESSWIRE
    09 Jan 2026
    Share Share
    Peijia Medical Gets NMPA Approval For Taurustrio Valve System
    Peijia Medical Gets NMPA Approval For Taurustrio Valve System

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/peijia-medical-receives-nmpa-approval-for-taurustrio-transcatheter-aortic-valve-system-pioneering-treatment-for-aortic-regurgitation-in-china-302640106.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search